<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    12603968
   </pmid>
   <datecreated>
    <year>
     2003
    </year>
    <month>
     02
    </month>
    <day>
     26
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2004
    </year>
    <month>
     07
    </month>
    <day>
     20
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2005
    </year>
    <month>
     01
    </month>
    <day>
     13
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      1462-3846
     </issn>
     <journalissue citedmedium="Print">
      <issue>
       8
      </issue>
      <pubdate>
       <year>
        2002
       </year>
       <month>
        Dec
       </month>
      </pubdate>
     </journalissue>
     <title>
      Clinical evidence
     </title>
     <isoabbreviation>
      Clin Evid
     </isoabbreviation>
    </journal>
    <articletitle>
     Scabies.
    </articletitle>
    <pagination>
     <medlinepgn>
      1745-52
     </medlinepgn>
    </pagination>
    <affiliation>
     UNFPA Country Technical Services Team for Eastern Europe and Central Asia, Bratislava, Slovak Republic.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Walker
      </lastname>
      <forename>
       Godfrey
      </forename>
      <initials>
       G
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Johnstone
      </lastname>
      <forename>
       Paul
      </forename>
      <initials>
       P
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Review
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     Clin Evid
    </medlineta>
    <nlmuniqueid>
     100883600
    </nlmuniqueid>
    <issnlinking>
     1462-3846
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Toluidines
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      52645-53-1
     </registrynumber>
     <nameofsubstance>
      Permethrin
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      58-89-9
     </registrynumber>
     <nameofsubstance>
      Lindane
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      70288-86-7
     </registrynumber>
     <nameofsubstance>
      Ivermectin
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="UpdateIn">
     <refsource>
      Clin Evid. 2003 Dec;(10):1910-8
     </refsource>
     <pmid version="1">
      15555185
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="UpdateOf">
     <refsource>
      Clin Evid. 2002 Jun;(7):1543-8
     </refsource>
     <pmid version="1">
      12230770
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ivermectin
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Lindane
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Permethrin
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Scabies
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Toluidines
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <numberofreferences>
    31
   </numberofreferences>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2003
     </year>
     <month>
      2
     </month>
     <day>
      27
     </day>
     <hour>
      4
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2004
     </year>
     <month>
      7
     </month>
     <day>
      21
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2003
     </year>
     <month>
      2
     </month>
     <day>
      27
     </day>
     <hour>
      4
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     12603968
    </articleid>
    <articleid idtype="pii">
     1707
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

